Sriwongjanya, 1996 - Google Patents
Pharmaceutical applications of ion exchange resinsSriwongjanya, 1996
- Document ID
- 5611334242157722209
- Author
- Sriwongjanya M
- Publication year
External Links
Snippet
Ion exchange can be defined as a reversible exchange of ions between a solid and a liquid in which there is no substantial change in the structure of the solid. Ion-exchangers are usually water-insoluble solid substances which can take up ions of positive or negative …
- 239000003456 ion exchange resin 0 title abstract description 128
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
- A61K47/48176—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly(meth)acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol
- A61K47/48184—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly(meth)acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol the macromolecular compound obtained by reactions only involving carbon-to-carbon unsaturated bonds being an ion exchange resin, e.g. polystyrene sulfonic acid resin
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0367746B1 (en) | Sustained release drug-resin complexes | |
| Guo et al. | Ion-exchange resins as drug delivery carriers | |
| US4221778A (en) | Prolonged release pharmaceutical preparations | |
| Borodkin | Ion-exchange resin delivery systems | |
| DK160601B (en) | PHARMACEUTICAL RESPONSIBLE, SUSTAINED RELEASE PREPARATION WITH CONTROLLED RELEASE OF A PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALT OF DEXTROMETHORPHAN AND PROCEDURES FOR PREPARING THEREOF | |
| US5707656A (en) | Pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof | |
| WO2006101536A1 (en) | Fast-melting tablets having taste-masking and sustained release properties | |
| US4859461A (en) | Coatable ion exchange resins | |
| Irwin et al. | Drug-delivery by ion-exchange: part IIII: interaction of ester pro-drugs of propranolol with cationic exchange resins | |
| KR100240362B1 (en) | Colestipol hydrochloride high-content tablets | |
| Motycka et al. | Preparation and evaluation of microencapsulated ion-exchange resin beads | |
| IE870789L (en) | Coatable ion exchange resins | |
| AU663695B2 (en) | Polyamine drug-resin complexes | |
| CA1086226A (en) | Ion exchange resin prolonged release pharmaceutical preparations | |
| CA1283497C (en) | Polymer-treated ion exchange resins | |
| Sriwongjanya | Pharmaceutical applications of ion exchange resins | |
| Suhagiya et al. | Taste masking by ion exchange resin and its new applications: A review | |
| AU666887B2 (en) | New drug formulations with ion-exchangers | |
| Boylan et al. | Molecular-scale drug entrapment as a precise method of controlled drug release IV: Entrapment of anionic drugs by polymeric gelation | |
| KR101269766B1 (en) | Ion binding polymers and uses thereof | |
| Akkaramongkolporn et al. | Effect of a pharmaceutical cationic exchange resin on the properties of controlled release diphenhydramine hydrochloride matrices using Methocel K4M or Ethocel 7cP as matrix formers | |
| Bajpai et al. | Ion exchange resins in drug delivery | |
| Mhetre et al. | Ion Exchange Resin: A novel drug delivery system an overview | |
| US5068111A (en) | Pharmaceutical tablets and capsule granulates of scleroglucan and active substance | |
| Atyabi | Preparation and potential applications of floating formulations based on ion exchange resins |